Induction chemoradiotherapy followed by surgery for locally advanced non-small cell lung cancer

Oncology Reports

Volumn 22, Issue 5, 2009, Pages 1157-1162

  Kusumoto, Sojiro ^a   Hirose, Takashi ^a   Fukayama, Motoko ^a   Kataoka, Daisuke ^a   Hamada, Kenji ^a   Sugiyama, Tomohide ^a   Shirai, Takao ^a   Yamaoka, Toshimitsu ^a   Okuda, Kentaro ^a   Ohnishi, Tsukasa ^a   Ohmori, Tohru ^a   Kadokura, Mitsutaka ^a   Adachi, Mitsuru ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cisplatin; Induction chemoradiotherapy; Non small cell lung cancer; Surgery; Vinorelbine

Indexed keywords

CISPLATIN; GRANULOCYTE COLONY STIMULATING FACTOR; NAVELBINE;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; BLOOD TOXICITY; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CREATININE BLOOD LEVEL; DIARRHEA; DRUG DOSE REDUCTION; DRUG FEVER; DRUG TOLERABILITY; DRUG WITHDRAWAL; ESOPHAGITIS; FEBRILE NEUTROPENIA; FEMALE; HUMAN; INFECTION; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUTROPENIA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION PNEUMONIA; SIDE EFFECT; SURVIVAL TIME; THORACOTOMY; THROMBOCYTOPENIA;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PNEUMONECTOMY; PROGNOSIS; RADIOTHERAPY DOSAGE; REMISSION INDUCTION; SURVIVAL RATE; TREATMENT OUTCOME; VINBLASTINE; YOUNG ADULT;

EID: 70449447990     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000549     Document Type: Article

References (27)

1. Jemal A, Tiwari RC, Murray T, et al: American Cancer Society: Cancer Statistics, 2004. CA Cancer J Clin 54: 8-29, 2004.
2. Mountain CF: Revisions in the international system for staging lung cancer. Chest 111: 1710-1717, 1997.
3. Perez CA, Stanley K, Grundy G, et al: Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung. Cancer 50: 1091-1099, 1982.
4. Rosell R, Gómez-Codina J, Camps C, et al: A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med 330: 153-158, 1994.
5. Roth JA, Fossella F, Komaki R, et al: A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer. J Natl Cancer Inst 86: 673-680, 1994.
6. Burdett S, Stewart LA and Rydzewska L: A systematic review and meta-analysis of the literature: chemotherapy and surgery versus surgery alone in non-small cell lung cancer. J Thorac Oncol 1: 611-621, 2006.
7. Depierre A, Milleron B, Moro-Sibilot D, et al: French Thoracic Cooperative Group: preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II and IIIA non-small cell lung cancer. J Clin Oncol 20: 247-253, 2002.
8. Albain KS, Rusch VW, Crowley JJ, et al: Concurrent cisplatin/ etoposide plus chest radiotherapy followed by surgery for stage IIIA (N2) and IIIB non-small cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 13: 1880-1892, 1995.
9. Choi NC, Carey RW, Daly W, et al: Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small cell lung cancer. J Clin Oncol 15: 712-722, 1997.
10. Katakami N, Okazaki M, Nishiuchi S, et al: Induction chemoradiotherapy for advanced stage III non-small cell lung cancer: long-term follow-up in 42 patients. Lung Cancer 22: 127-137, 1998.
11. Eberhardt W, Wilke H, Stamatis G, et al: Preoperative chemotherapy followed by concurrent chemoradiotherapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial. J Clin Oncol 16: 622-634, 1998.
12. Trodella L, Granone P, Valente S, et al: Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small cell lung cancer: long-term results according to downstaging. Ann Oncol 15: 389-398, 2004.
13. Albain KS, Scott CB, Rusch VR, Turrisi AT, Shepherd FA, Smith C for RTOG, SWOG, NCIC, ECOG, CALGB, NCCTG: Phase III comparison of concurrent chemotherapy plus radiotherapy (CT/radiotherapy) and CT/radiotherapy followed by surgical resection for stage IIIA (pN2) non-small cell lung cancer (NSCLC): initial results from Intergroup trial 0139 (RTOG 93-09). Proc Am Soc Clin Oncol 22: 621, 2003.
14. Le Chevalier T, Brisgand D, Douilland JY, et al: Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbin alone in advanced non-small cell lung cancer: results of a European multicentre trial including 612 patients. J Clin Oncol 12: 360-367, 1994.
15. Dewit L: Combined treatment of radiation and cis-diammine-dichloroplatinum II: a review of experimental and clinical data. Int J Radiat Oncol Bio Phys 13: 403-426, 1987.
16. Edelstein MP, Wolfe LA III and Duch DS: Potentiation of radiation therapy by vinorelbine (Navelbine) in non-small cell lung cancer. Semin Oncol 23: 41-47, 1996.
17. Farray D, Mirkovic N and Albain KS: Multimodality therapy for stage III non-small cell lung cancer. J Clin Oncol 23: 3257-3269, 2005.
18. Lorent N, De Leyn P, Lievens Y, et al: Long-term survival of surgically staged IIIA-N2 non-small cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience. Ann Oncol 15: 1645-1653, 2004.
19. Macchiarini P, Chapelier AR, Monnet I, et al: Extended operations after induction therapy for stage IIIB (T4) non-small cell lung cancer. Ann Thorac Surg 57: 966-973, 1994.
20. Van Meerbeeck JP, Kramer GW, van Schil PE, et al: European Organisation for Research and Treatment of Cancer-Lung Cancer Group: randomized controlled trail of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer. J Natl Cancer Inst 99: 442-450, 2007.
21. Martin J, Ginsberg RJ, Abolhoda A, et al: Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy. Ann Thorac Surg 72: 1149-1154, 2001.
22. Pignon JP, Tribodet H, Scagliotti GV, et al: LACE Collaborative Group: Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol 26: 3552-3559, 2008.
23. The International Adjuvant Lung Cancer Trial Collaborative Group: Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small cell lung cancer. N Eng J Med 350: 351-360, 2004.
24. Steinert HC, Hauser M, Allemann F, Engel H, Berthold T, von Schulthess GK and Weder W: Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology 202: 441-446, 1997.
25. Gdeedo A, van Schil P, Corthouts B, van Mieghem F, van Meerbeeck J and van Marck E: Prospective evaluation of computed tomography and mediastinoscopy in mediastinal lymph node staging. Eur Resp J 10: 1547-1551, 1997.
26. Pieterman RM, van Putten JW, Meuzelaar JJ, et al: Preoperative staging of non-small cell lung cancer with positron-emission tomography. N Eng J Med 343: 254-261, 2000.
27. Webb WR, Gatsonis C, Zerhouni EA, Heelan RT, Glazer GM, Francis IR and McNeil BJ: CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the radiologic diagnostic oncology group. Radiology 178: 705-713, 1991.